Miyakita Y - Search Results

1

Boron neutron capture therapy prolongs survival in a patient with a recurrent malignant peripheral nerve sheath tumor-A case report.

Watanabe Y, Chen YW, Igaki H, Arakawa A, Tao K, Sugiyama M, Nakajima M, Shirakawa N, Yanagisawa S, Miyakita Y, Yoshida A, Isohashi K, Ono K, Narita Y, Ogawa C. Watanabe Y, et al. Among authors: miyakita y. Pediatr Blood Cancer. 2024 Jul;71(7):e31011. doi: 10.1002/pbc.31011. Epub 2024 Apr 14. Pediatr Blood Cancer. 2024. PMID: 38616403 No abstract available.

2

Early Diagnosis and Surgical Intervention Within 3 Weeks From Symptom Onset Are Associated With Prolonged Survival of Patients With Glioblastoma.

Kawauchi D, Ohno M, Miyakita Y, Takahashi M, Yanagisawa S, Omura T, Yoshida A, Kubo Y, Igaki H, Ichimura K, Narita Y. Kawauchi D, et al. Among authors: miyakita y. Neurosurgery. 2022 Nov 1;91(5):741-748. doi: 10.1227/neu.0000000000002096. Epub 2022 Aug 15. Neurosurgery. 2022. PMID: 35951724 Free PMC article.

3

Assessment of therapeutic outcome and role of reirradiation in patients with radiation-induced glioma.

Ohno M, Miyakita Y, Takahashi M, Yanagisawa S, Tamura Y, Kawauchi D, Kikuchi M, Igaki H, Yoshida A, Satomi K, Matsushita Y, Ichimura K, Narita Y. Ohno M, et al. Among authors: miyakita y. Radiat Oncol. 2022 May 3;17(1):85. doi: 10.1186/s13014-022-02054-x. Radiat Oncol. 2022. PMID: 35505351 Free PMC article.

4

Continuing maintenance temozolomide therapy beyond 12 cycles confers no clinical benefit over discontinuation at 12 cycles in patients with IDH1/2-wildtype glioblastoma.

Ohno M, Miyakita Y, Takahashi M, Yanagisawa S, Tamura Y, Narita Y. Ohno M, et al. Among authors: miyakita y. Jpn J Clin Oncol. 2022 Oct 6;52(10):1134-1142. doi: 10.1093/jjco/hyac114. Jpn J Clin Oncol. 2022. PMID: 35858227

5

Consulting a neurosurgeon upon initial medical assessment reduces the time to the first surgery and potentially contributes to improved prognosis for glioblastoma patients.

Kawauchi D, Ohno M, Miyakita Y, Takahashi M, Yanagisawa S, Omura T, Yoshida A, Kubo Y, Igaki H, Ichimura K, Narita Y. Kawauchi D, et al. Among authors: miyakita y. Jpn J Clin Oncol. 2023 Nov 5;53(11):1027-1033. doi: 10.1093/jjco/hyad093. Jpn J Clin Oncol. 2023. PMID: 37534529

6

The late recurrence of ganglioneuroma 21 years after initial presentation with neuroblastoma.

Okita Y, Narita Y, Yoshida A, Miyakita Y, Ohno M, Saio M, Yoshimi N, Shibui S. Okita Y, et al. Among authors: miyakita y. Pediatr Hematol Oncol. 2012 Oct;29(7):647-51. doi: 10.3109/08880018.2012.721871. Epub 2012 Sep 11. Pediatr Hematol Oncol. 2012. PMID: 22966943

7

Impact of Surgical Margin in Skull Base Surgery for Head and Neck Sarcomas.

Kobayashi K, Matsumoto F, Miyakita Y, Mori T, Shimoi T, Murakami N, Yoshida A, Arakawa A, Omura G, Fukasawa M, Matsumoto Y, Matsumura S, Itami J, Narita Y, Yoshimoto S. Kobayashi K, et al. Among authors: miyakita y. J Neurol Surg B Skull Base. 2018 Oct;79(5):437-444. doi: 10.1055/s-0037-1615816. Epub 2018 Jan 9. J Neurol Surg B Skull Base. 2018. PMID: 30210970 Free PMC article.

8

Prognostic factors of brain metastases from colorectal cancer.

Imaizumi J, Shida D, Narita Y, Miyakita Y, Tanabe T, Takashima A, Boku N, Igaki H, Itami J, Kanemitsu Y. Imaizumi J, et al. Among authors: miyakita y. BMC Cancer. 2019 Jul 31;19(1):755. doi: 10.1186/s12885-019-5973-x. BMC Cancer. 2019. PMID: 31366387 Free PMC article.

9

Survival benefits of hypofractionated radiotherapy combined with temozolomide or temozolomide plus bevacizumab in elderly patients with glioblastoma aged ≥ 75 years.

Ohno M, Miyakita Y, Takahashi M, Igaki H, Matsushita Y, Ichimura K, Narita Y. Ohno M, et al. Among authors: miyakita y. Radiat Oncol. 2019 Nov 12;14(1):200. doi: 10.1186/s13014-019-1389-7. Radiat Oncol. 2019. PMID: 31718669 Free PMC article.

10

Outcomes of salvage fractionated re-irradiation combined with bevacizumab for recurrent high-grade gliomas that progressed after bevacizumab treatment*.

Yonezawa H, Ohno M, Igaki H, Miyakita Y, Takahashi M, Tamura Y, Shima S, Matsushita Y, Ichimura K, Narita Y. Yonezawa H, et al. Among authors: miyakita y. Jpn J Clin Oncol. 2021 Jul 1;51(7):1028-1035. doi: 10.1093/jjco/hyab063. Jpn J Clin Oncol. 2021. PMID: 33959771 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

100 results

Search Page